Open Access<p>Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population</p>
Author(s) -
Angelica Petrillo,
Giuseppe Tirino,
Federica Zito Marino,
Luca Pompella,
Rosalaura Sabetta,
Iacopo Panarese,
Marianna Caterino,
Anna Ventriglia,
Maria Maddalena Laterza,
Floriana Morgillo,
Michele Orditura,
Fortunato Ciardiello,
Renato Franco,
Ferdinando De Vita
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s229813
Subject(s) - nivolumab , medicine , cancer , population , oncology , immunotherapy , gastroenterology , environmental health
ATTRACTION-2 trial assessed the role of Nivolumab as a new standard treatment for Asian patients with pretreated metastatic gastric cancer (mGC). The aim of this analysis was to evaluate the safety and efficacy of Nivolumab in a real-life Western population, considering the lack of evidence to date.